Fomento Económico Mexicano, S.A.B. de C.V. FMX ← Back to all reports

Fomento Económico Mexicano, S.A.B. de C.V.

FMX · Consumer Staples
A ★★★★ Buy
Oct 31, 2026 · Score 83 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $126.10
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $119.00 ($115.00–$123.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $136.40
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative Expected Return means the Price Target is below the report-date Current Price. This can occur even with a Buy or Strong Buy recommendation because recommendations follow a fixed mapping from the overall investment score, which combines business assessment, valuation and risk. This is a limitation of our score-based framework: a favorable recommendation does not always imply an attractive entry price. Consider the Price Target, Buy Zone and valuation analysis together.
Methodology →
+8.2%

Type A - Fomento Económico Mexicano, S.A.B. de C.V. (FMX) 20261031 Stock Analysis

📅 FEMSA Key Upcoming Events

🏢 Step 1: FEMSA Company Overview & Business Model

Q1-A1. What is FEMSA?

Q1-A2. How Does FEMSA Make Money?

Q1-A3. FEMSA’s Revenue Segments & Core Income Sources

Q1-A4. Who Are FEMSA’s Competitors?

Q1-A5. FEMSA Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: FEMSA’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does FEMSA Have a Durable Economic Moat?

Q2-A2. Is FEMSA’s Growth Sustainable?

Q2-A3. How Does FEMSA Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is FEMSA Profitable? Financial Health Analysis

Q3-A2. How Profitable Is FEMSA? (Margins & ROIC)

Q3-A3. What Drives FEMSA’s Returns? (ROIC Breakdown)

Q3-A4. Are FEMSA’s Earnings High Quality?

Q3-A5. Is FEMSA’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: FEMSA Forensic Accounting & Dilution Review

Q4-A1. Does FEMSA Have Accounting Red Flags?

Q4-A2. Is FEMSA Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is FEMSA’s Cash Flow?

Q4-A4. Is FEMSA Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: FEMSA Management & Shareholder Alignment

Q5-A1. Can You Trust FEMSA’s Management? (Guidance Track Record)

Q5-A2. What Are FEMSA Insiders Doing?

Q5-A3. Is FEMSA’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: FEMSA Market Flow & Sentiment

Q6-A1. Analyst Consensus vs FEMSA Guidance

Q6-A2. What Is FEMSA’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: FEMSA Catalysts & Price Triggers

Q7-A1. What Could Move FEMSA Stock? (Top 3 Catalysts)

Q7-A2. FEMSA’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is FEMSA Fairly Valued? Valuation Analysis

Q8-A1. FEMSA’s Key Valuation Multiples

Q8-A2. FEMSA vs Peers: Valuation Comparison

Q8-A3. Is FEMSA Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into FEMSA? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From FEMSA? (Reverse DCF Alternative)

Q8-A5. FEMSA’s Hidden Asset & Stake Valuation

Q8-A6. Final Valuation Adjustment

Q8-A7. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of FEMSA? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to FEMSA?

Q9-A2. How Sensitive Is FEMSA to the Economy?

Q9-A3. FEMSA Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: FEMSA Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy FEMSA? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. FEMSA’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is FEMSA’s Persistent European and Pharmacy Margin Weakness Its Biggest Structural Vulnerability?

Q2: Can FEMSA’s 22.57x Forward P/E Be Justified by Its Retail Recovery and Beverage Franchise?

Q3: Can FEMSA Sustain OXXO Mexico’s 9.2% Same-Store Sales Growth?

Q4: Is Coca-Cola FEMSA the Most Reliable Source of FEMSA’s Long-Term Cash Generation?

Q5: Does FEMSA’s International Expansion Create More Value Than Reinvesting in Mexico?

Q6: Can FEMSA’s Spin Ecosystem Become a Meaningful Profit Driver Beyond OXXO Retail?

Q7: How Much Could FEMSA’s Earnings Improve if Europe and Health Recover?

Q8: Is FEMSA’s Low P/FCF Multiple Evidence of Undervaluation or a Cash-Flow Accounting Trap?

Q9: Could Mexican Peso Volatility Undermine FEMSA’s USD-Denominated Investment Returns?

Q10: Can FEMSA Sustain Its Dividend and Share Repurchases Without Sacrificing Growth?

Rating History

Rating History shows the Rating assigned on each report date. Only the latest report is available to read. Scores are omitted from the timeline because reports from different periods may follow different rating scales.

  1. 2026-07 B
  2. 2026-08 A
  3. 2026-10-25 A
  4. 2026-10-31 A